Volume 33 Issue 1
Jan.  2017
Turn off MathJax
Article Contents
NI Wei-bing, YAO Zu-pei, GE Fang-qing, ZHENG Xiao-dan, CAI Juan, PENG Jin-xiang, SU Hai-yan. Clinical Research of Shuangxin Decoction on Coronary Heart Disease Accompanied with Psychological Disorder[J]. Journal of Nanjing University of traditional Chinese Medicine, 2017, 33(1): 26-29.
Citation: NI Wei-bing, YAO Zu-pei, GE Fang-qing, ZHENG Xiao-dan, CAI Juan, PENG Jin-xiang, SU Hai-yan. Clinical Research of Shuangxin Decoction on Coronary Heart Disease Accompanied with Psychological Disorder[J]. Journal of Nanjing University of traditional Chinese Medicine, 2017, 33(1): 26-29.

Clinical Research of Shuangxin Decoction on Coronary Heart Disease Accompanied with Psychological Disorder

More Information
  • OBJECTIVE To explore the clinical effects of Shuangxin Decoction in treating coronary heart disease accompanied with psychological disorder. METHODS 80 cases with coronary heart disease manifested as chest pain, chest distress plus psychological disorders like depression and anxiety were randomly divided into treatment group and control group. Patients in both groups were treated with routine western medicine plus psychological counseling. Based on which, patients in the treatment group were further given Chinese medicine Shuangxin Decoction, while those in the control group were added deanxit, with the course lasting for 6 weeks. Chest pain(distress) integral score scale, traditional Chinese medicine(TCM) syndrome score scale and comprehensive hospital anxiety and depression scale were evaluated to explore the therapeutic effects of chest pain, psychological disorder and clinical TCM syndromes before and after treatment of both groups, together with the changes of electrocardiogram test results and cardiac markers. RESULT Chest pain(distress) integral scores of treatment group were lower than those of control group(P<0.05), with the total curative rate being 82.50%, notably higher than 52.5% of the control group(P<0.01). The anxiety and depression scores of both groups were evidently reduced after treatment(P<0.01). The comparison of the two groups was P>0.05. TCM syndrome scores of both groups were notably declined(P<0.01). The total curative rate was 75%, which was superior to 20% of the control group(P<0.01). Both electrocardiogram test results and cardiac markers in both groups experienced an evident improvement than before(P<0.05). The comparison of the two groups showed P>0.05. No abnormality was detected in blood, urine, stool or liver and kidney function test in patients of both groups. CONCLUSION Shuangxin Decoction can efficiently improve chest pain, chest distress symptoms as well as TCM clinical syndromes due to coronary heart disease accompanied with psychological disorder. Also, it is helpful for improving depression and anxiety, which has been considered as a safe and effective formula for treating these two disorders, worthy of clinical application and promotion.
  • Cited by

    Periodical cited type(6)

    1. 陈杨,朱梓强,陆韫青,郑嘉妮,曹程,仝佳祥,李璇,郭盛,康宏杰,段金廒,朱悦. 杞参益智方改善D-半乳糖注射亚急性衰老模型小鼠学习与记忆能力的效应评价研究. 南京中医药大学学报. 2024(02): 37-44 . 本站查看
    2. 户京京,张晓光,杨建会,王南,丁辉,宋新波. 开心散神经系统作用现代研究. 辽宁中医药大学学报. 2022(01): 61-66 .
    3. 张静,周亚男,唐于平,段金廒,周桂生. 中西药联合应用治疗阿尔茨海默病的研究进展. 现代医药卫生. 2022(02): 235-238 .
    4. 孟雪儿,楼倩颖,曹程,王青青,佘雨岩,白加德,丁玉华,段金廒,朱悦,赵明. 麋角丸改善Aβ_(1-42)海马区注射小鼠学习与记忆能力的作用机制研究. 世界科学技术-中医药现代化. 2022(01): 78-87 .
    5. 王瑾,周小江,胡园,陈超,段冬梅,刘屏,董宪喆. 开心散药效物质基础和药理作用机制的研究进展. 中草药. 2020(18): 4780-4788 .
    6. 张静,史旭芹,周桂生,谭亚杰,陈嘉倩,陶慧娟,濮宗进,刘培,朱悦,钱大玮,唐于平,段金廒. 基于主成分分析和多指标综合指数法对银杏酮酯-多奈哌齐不同量比抗痴呆作用比较研究. 药学学报. 2019(04): 660-669 .

    Other cited types(8)

Catalog

    Article Metrics

    Article views (1442) PDF downloads (1351) Cited by(14)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return